Presentations & Videos

CFO Michael Schneiders:  9M Financial Results 2025/26 | Enzymes, BioIncubator & Outlook

(Date of recording September 10, 2026)

CFO Michael Schneisers presents: What is BRAIN Biotech all about? The Equity Story and why you should consider an investment?

(Date of recording: August 18, 2026)

Elevator Pitch from CFO Michael Schneiders
(Date of recording: June 30, 2026)

CFO Michael Schneiders: Financial Results H1 2025/26 - Enzyme business with sequential growth; continuing positive news flow from the BioIncubator & full year guidance confirmed

In the FY 2024/25 results presentation, Michael Schneiders, Chief Financial Officer, outlines how Brain Biotech is progressing from a technology-driven innovation platform toward a more cash-generative, scalable industrial biotechnology group.

Michael Schneiders, CFO of BRAIN Biotech AG, adresses the seven most frequently asked questions from institutional investors,  providing insights, perspectives, and a forward-looking outlook on topics ranging from AI-powered enzyme discovery and U.S. expansion to M&A strategy and the commercial pipeline within the BRAINBioIncubator portfolio.

CFO Michael Schneiders: Strong Core Growth & BioIncubator Innovations

Elevator Pitch from CFO Michael Schneiders
(Date of recording: June 4, 2025)

CFO Michael Schneiders: Financial Results H1 2024/25 | Innovation Momentum and Strategic Focus

CFO Michael Schneiders: Financial Results Q1 2024/25 | Growth, Innovation & Outlook